CTLA-4-blocking immunotherapy with ipilimumab for advanced melanoma.

CTLA-4-blocking immunotherapy with ipilimumab for advanced melanoma. Oncology (Williston Park). 2010 Dec; 24(14):1302, 1304.

View in: PubMed